venezuelan
equin
enceph
viru
veev
one
neglect
virus
among
biowarfar
agent
classifi
categori
b
biothreat
pathogen
nation
institut
allergi
infecti
diseas
niaid
usa
due
high
dissemin
rate
minim
infecti
dose
induc
diseas
human
requir
specif
enhanc
diagnost
capac
veev
caus
diseas
symptom
rang
influenzalik
ill
sever
ill
includ
myalgia
arthralgia
neurolog
disord
lead
lethal
enceph
suscept
host
characterist
made
veev
attract
candid
weapon
veev
first
isol
infect
hors
brain
veev
outbreak
venezuela
follow
major
outbreak
venezuela
columbia
infect
thousand
peopl
anim
despit
high
contagi
veev
drawn
littl
public
attent
due
sporad
outbreak
occur
central
south
america
sinc
reason
neglect
may
low
mortal
rate
human
high
hors
well
report
veev
outbreak
us
sinc
epidem
outbreak
texa
howev
spillov
veev
infect
infect
hors
human
epidem
remain
concern
veev
arthropodborn
epizoot
rna
viru
belong
togavirida
famili
genu
alphaviru
maintain
within
lower
anim
rodent
mosquito
transmiss
veev
primarili
mediat
mosquito
replic
salivari
gland
pass
host
human
hors
overt
symptom
moreov
aerosol
veev
directli
dissemin
infect
human
suscept
experiment
anim
model
caus
enceph
possibl
limb
paralysi
histor
sinc
late
former
soviet
union
regard
veev
oper
biolog
weapon
incapacit
rear
servic
reinforc
behind
front
line
lead
spread
diseas
among
infect
individu
flulik
symptom
difficult
distinguish
epidem
influenza
outbreak
weapon
veev
expect
kill
soldier
caus
panic
ultim
maim
militari
target
notabl
effect
antivir
agent
avail
approv
us
food
drug
administr
fda
support
treatment
avail
human
result
import
establish
prevent
surveil
system
base
prompt
diagnosi
method
viral
stabil
essenti
factor
diagnosi
veev
confirm
presenc
virion
viral
rna
clinic
sampl
current
diagnost
approach
confirm
veev
infect
human
hors
reli
direct
detect
viral
nucleic
acid
serum
spinal
fluid
sampl
acutephas
infect
use
reversetranscript
pcr
rtpcr
elisa
veevspecif
igm
howev
despit
high
sensit
abovement
method
fals
neg
result
obtain
sampl
collect
initi
asymptomat
phase
infect
viral
load
low
moreov
necess
extra
step
plasma
serum
prepar
complic
fast
viru
identif
diagnost
therefor
viru
stabil
directli
collect
sampl
without
extra
prepar
step
highli
desir
ideal
supplement
blood
collect
devic
type
stabil
agent
minim
pathogen
loss
sampl
transport
storag
ambient
temperatur
appeal
view
challeng
nt
particl
evalu
abil
stabil
veev
nt
particl
hydrogel
polym
particl
compris
nisopropylacrylamid
nipam
allylamin
aa
crosslink
n
bi
particl
function
variou
dye
affin
bait
facilit
captur
retent
analyt
complex
biolog
matrix
blood
saliva
nasal
swab
urin
concentr
smaller
volum
previou
work
nt
particl
shown
benefit
use
enrich
infecti
viru
viral
genom
materi
rift
valley
fever
viru
rvfv
coronaviru
influenza
viru
respiratori
syncytia
viru
studi
sought
appli
new
magnet
nt
particl
consist
nipam
copolym
function
reactiv
red
evalu
efficaci
preserv
infecti
veev
viral
rna
veev
capsid
protein
whole
blood
sampl
ambient
elev
temperatur
well
low
high
humid
condit
result
indic
magnet
nt
particl
enhanc
preserv
infecti
veev
whole
human
blood
ii
nt
maintain
significantli
higher
level
veev
rna
whole
human
blood
iii
nt
retain
function
activ
normal
elev
humid
condit
significantli
preserv
veev
infect
environ
iv
blood
sampl
veev
infect
anim
better
protect
capsid
protein
degrad
incub
nt
result
demonstr
first
time
capabl
nt
particl
stabil
viru
blood
elev
temperatur
direct
interact
nt
particl
veev
via
transmiss
electron
microscopi
util
nt
particl
viral
clinic
sampl
viral
stock
produc
electropor
vitro
transcrib
viral
rna
gener
plasmid
kind
gift
ilya
frolov
univers
texa
medic
branch
galveston
describ
experi
perform
condit
whole
human
blood
plasma
purchas
bioivt
wwwbioivtcom
nt
particl
provid
cere
nanosci
manassa
va
ceresnanocom
veev
dilut
pfuml
whole
human
blood
follow
incub
nt
particl
suspens
mg
ntml
sampl
mg
ntml
sampl
without
nt
particl
rotat
min
room
temperatur
viral
rna
purifi
use
rneasi
kit
qiagen
amount
viral
rna
determin
rtqpcr
use
iii
green
onestep
qpcr
kit
wrox
thermo
fisher
scientif
follow
set
primer
integr
dna
technolog
taqman
probe
n
design
rna
packag
signal
describ
previous
rtqpcr
perform
use
stepon
plu
real
time
pcr
system
instrument
abi
fold
enrich
calcul
base
enrich
viral
genom
copi
number
divid
without
nt
particl
group
veev
dilut
pfuml
whole
human
blood
plasma
follow
incub
without
nt
particl
indic
humid
temperatur
condit
variou
time
point
viral
rna
purifi
use
combin
ls
ambion
rneasi
mini
kit
qiagen
briefli
whole
human
blood
contain
viral
virion
mix
ratio
trizol
ls
hundr
microlit
pb
ad
sampl
order
increas
amount
aqueou
fraction
sampl
vortex
chloroform
ad
blood
trizol
ls
mixtur
intens
vortex
spin
upper
aqueou
fraction
contain
nucleic
acid
collect
use
rna
purif
rneasi
kit
qiagen
accord
manufactur
protocol
purifi
rna
use
cdna
synthesi
follow
pcr
reaction
cycl
use
one
step
rtpcr
kit
thermofish
scientif
purpos
follow
set
primer
use
ctc
gcc
aat
gtg
acg
ctg
ctc
tgt
tga
cta
tag
tgt
tat
visual
quantiti
viral
cdna
pcr
product
load
agaros
gel
supplement
ethidium
bromid
follow
gel
electrophoresi
sampl
visual
chemidoc
instrument
biorad
densitometr
analyz
use
imag
lab
softwar
biorad
pfu
veev
spike
whole
human
blood
supplement
mg
ntml
sampl
supplement
nt
particl
sampl
incub
indic
temperatur
humid
condit
design
amount
time
end
incub
nt
particl
contain
sampl
place
magnet
rack
separ
nt
particl
blood
particl
resuspend
pb
use
standard
plaqu
assay
describ
elsewher
sampl
incub
without
nt
particl
process
use
method
veev
dilut
pfuml
plasma
follow
incub
without
nt
particl
mg
ntml
sampl
indic
humid
temperatur
condit
variou
time
point
blue
lysi
buffer
novex
trisglycin
sampl
load
buffer
sd
tper
tissu
protein
extract
reagent
edta
complet
proteas
cocktail
tablet
naf
dtt
ad
sampl
volum
ratio
follow
boil
min
protein
lysat
electrophores
bistri
sdspage
gel
transfer
pvdf
membran
dilut
primari
antiveev
capsid
antibodi
cat
bei
manassa
va
usa
nonfat
milk
block
buffer
appli
membran
overnight
incub
follow
wash
pb
tween
three
time
horseradish
peroxidas
hrp
conjug
antigoat
igg
secondari
antibodi
thermofish
scientif
dilut
incub
membran
h
room
temperatur
membran
wash
addit
three
time
pb
tween
ad
west
femto
maximum
sensit
substrat
thermofish
scientif
develop
membran
imag
chemiluminesc
signal
sampl
visual
chemidoc
instrument
biorad
densitometr
analyz
imag
lab
softwar
biorad
total
mice
randomli
divid
three
group
n
dilut
pfuml
pb
follow
intranas
administr
anesthet
mice
amount
day
postinfect
mice
sacrif
time
point
blood
collect
edtatr
tube
prevent
coagul
rtqpcr
perform
quantifi
level
viremia
sampl
highest
viremia
pool
togeth
incub
without
nt
particl
compar
capsid
stabil
western
blot
analysi
experi
perform
anim
biosafeti
level
laboratori
accord
nation
research
council
guid
care
use
laboratori
anim
georg
mason
univers
iacuc
protocol
number
veev
structur
protein
capsid
retriev
pdb
websit
id
chemic
structur
reactiv
red
download
chemspid
websit
heterodim
extract
total
protein
structur
molsoft
icmbrows
follow
submit
swissdock
predict
possibl
dock
pocket
dock
model
display
ballandstick
style
reactiv
red
residu
surfac
style
amino
acid
heterodim
repres
imag
select
base
two
lowest
free
energi
valu
subunit
insid
laboratori
biosafeti
cabinet
bsc
nt
suspens
mix
well
volum
glutaraldehyd
achiev
final
concentr
glutaraldehyd
viru
sampl
inactiv
glutaraldehyd
insid
bsc
h
accord
industri
standard
practic
prior
remov
transfer
em
facil
drop
glutaraldehyd
treat
sampl
place
onto
formvarcarbon
coat
transmiss
electron
microscopi
tem
grid
min
moist
chamber
reduc
evapor
step
ensur
grid
dri
use
fine
forcep
hold
grid
liquid
wick
away
grid
surfac
side
filter
paper
grid
wash
three
time
touch
grid
surfac
drop
deioniz
di
water
remain
water
wick
away
touch
filter
paper
side
grid
small
drop
phosphotungst
acid
pta
appli
grid
allow
remain
min
depend
sampl
stain
wick
away
touch
edg
grid
piec
filter
paper
grid
air
dri
room
temperatur
store
subsequ
tem
imag
tem
grid
evalu
jeol
transmiss
electron
microscop
kv
digit
imag
acquir
use
advanc
microscopi
techniqu
amt
camera
system
kruskalw
test
unpair
ttest
perform
throughout
studi
calcul
statist
signific
among
group
without
nt
particl
unless
indic
elsewher
nt
particl
contain
affin
bait
enabl
interact
analyt
poorli
defin
characterist
exampl
triazin
dye
cibacron
blue
reactiv
red
bind
protein
hydrophob
electrostat
interact
therefor
initi
step
studi
screen
panel
magnet
nt
particl
shown
tabl
evalu
efficaci
enrich
nt
particl
mix
bloodspik
mg
ntml
sampl
incub
min
prior
determin
viral
rna
level
rtqpcr
screen
differ
type
nt
particl
found
nt
particl
capabl
enrich
veev
differ
level
figur
b
confirm
test
limit
captur
effici
nt
particl
select
three
batch
nt
particl
shown
best
bind
effici
enrich
perform
mix
nt
particl
bloodspik
mg
ntml
sampl
nt
particl
capabl
enrich
veev
use
concentr
show
signific
enrich
boundunbound
figur
suggest
nt
particl
conjug
reactiv
red
chemic
bait
could
suitabl
follow
experi
also
compar
abil
nonmagnet
version
found
effect
captur
veev
supplement
figur
confirm
virion
captur
conduct
western
blot
analysi
toward
capsid
protein
capsid
protein
detect
sampl
incub
sampl
without
nt
particl
regardless
whether
viru
spike
blood
plasma
figur
data
demonstr
document
abil
nt
particl
enrich
viral
analyt
limit
detect
character
perform
util
variou
concentr
rang
sampl
without
nt
particl
mg
ntml
sampl
determin
optim
concentr
veev
capsid
enrich
detect
surpris
lower
concentr
mg
ntml
sampl
seem
exhibit
abund
enrich
higher
concentr
like
mg
ntml
sampl
figur
next
test
optim
incub
time
requir
nt
particl
captur
major
virion
sampl
thu
measur
viral
capsid
concentr
differ
incub
timepoint
earli
min
incub
veev
capsid
protein
detect
min
captur
abil
start
reach
satur
level
figur
data
show
magnet
nt
particl
provid
effici
captur
veev
virion
short
time
period
bind
effici
viral
sampl
optim
adjust
incub
time
nt
particl
concentr
base
data
chose
incub
time
min
nt
particl
concentr
mgml
sampl
remaind
experi
ensur
maxim
veev
captur
shown
previou
studi
nt
particl
captur
enrich
variou
virus
influenza
viru
rvfv
never
shown
nt
particl
directli
bind
virus
use
transmiss
electron
microscopi
tem
visual
direct
interact
nt
particl
virion
photo
figur
reveal
singl
nt
particl
capabl
captur
multipl
virion
tem
data
clearli
show
nt
particl
directli
interact
viral
particl
therefor
sought
elucid
site
interact
nt
particl
appli
dock
simul
via
swissdock
websit
determin
free
energi
bind
toward
affin
bait
reactiv
red
viral
envelop
protein
pdb
id
shown
figur
dock
predict
extern
domain
heterodim
protein
reveal
affin
bait
overal
interact
subunit
strongest
bind
predict
groov
panel
free
energi
nt
bind
subunit
summar
supplement
tabl
gener
predict
result
suggest
may
strong
interact
nt
particl
veev
envelop
protein
may
potenti
contribut
viral
enrich
exert
previou
studi
shown
nt
particl
effici
preserv
rvfv
nucleoprotein
biolog
relev
matric
howev
effect
nt
stabil
virion
complex
matrix
whole
human
blood
never
test
thu
determin
best
nt
composit
effici
captur
veev
next
step
test
stabil
viru
whole
blood
ambient
elev
temperatur
extend
time
period
purpos
spike
pfu
ml
human
whole
blood
incub
sampl
temperatur
h
follow
measur
viral
infect
plaqu
assay
observ
gradual
drop
viru
titer
wherea
viral
infect
remain
rel
consist
figur
howev
sever
attempt
incub
viru
h
repeatedli
result
complet
viru
inactiv
note
h
incub
blood
sampl
becam
solidifi
made
imposs
complet
resuspend
sampl
buffer
quantit
via
plaqu
assay
figur
therefor
exclud
possibl
viral
particl
captur
coagul
blood
still
remain
sampl
result
find
follow
experi
focu
primarili
temperatur
condit
next
investig
whether
prolong
stabil
human
whole
blood
found
stabil
veev
time
point
test
substanti
sustain
presenc
absenc
figur
wherea
infect
veev
h
incub
appear
better
preserv
despit
lack
statist
signific
figur
howev
note
four
repeat
observ
two
plaqu
develop
viru
h
incub
without
nt
contrast
four
repeat
abl
detect
virusproduc
plaqu
rang
plaqu
per
well
sampl
incub
presenc
indic
addit
sampl
may
stabil
veev
virion
preserv
infect
diagnost
purpos
primari
approach
confirm
veev
infect
suspect
clinic
case
base
detect
viru
specif
igm
neutral
antibodi
reaction
base
amplif
nucleic
acid
often
use
fatal
case
confirm
pathogen
presenc
rtqpcr
reliabl
method
highli
sensit
detect
minim
amount
viral
nucleic
acid
patient
sampl
howev
method
base
detect
rel
short
fragment
viral
genom
analysi
longer
stretch
viral
rna
vrna
would
provid
stringent
measur
rna
stabil
thu
investig
stabil
long
viral
rna
kb
product
rtpcr
short
vrna
bp
rtqpcr
veev
spike
blood
incub
presenc
absenc
indic
amount
time
follow
rna
purif
cdna
synthesi
pcr
qpcr
reaction
minim
differ
long
vrna
level
observ
sampl
incub
figur
overal
stabil
long
vrna
increas
detect
rtpcr
especi
higher
temperatur
condit
compar
sampl
incub
without
nt
particl
figur
densitometr
analysi
pcr
product
indic
preserv
long
vrna
presenc
h
incub
likewis
rtqpcr
result
indic
preserv
short
vrna
h
figur
comparison
also
monitor
degre
veev
capsid
protein
decay
presenc
absenc
given
difficulti
analysi
blood
sampl
via
western
blot
experi
perform
blood
dilut
pb
start
point
test
abil
prevent
capsid
protein
degrad
standard
blood
storag
condit
purpos
incub
viru
without
assess
westernblot
analysi
amount
capsid
protein
incub
sampl
even
though
veev
capsid
overal
stabl
observ
decreas
capsid
protein
detect
h
rescu
incub
figur
bottom
panel
western
blot
analysi
sampl
incub
also
demonstr
incub
capsid
preserv
avail
detect
figur
b
thu
nt
particl
profoundli
enrich
capsid
protein
sampl
temperatur
condit
presenc
capsid
protein
degrad
significantli
reduc
high
temperatur
result
rtpcr
protein
analys
suggest
could
effici
enrich
preserv
veev
rna
capsid
protein
harsh
temperatur
storag
condit
studi
shown
rel
humid
affect
stabil
airborn
virus
includ
aerosol
veev
therefor
investig
whether
could
contribut
bloodspik
veev
stabil
across
environment
humid
rang
place
viral
sampl
without
two
incub
rel
humid
incub
h
follow
determin
viral
titer
plaqu
assay
result
indic
viral
titer
bloodspik
preserv
humid
incub
h
postincub
figur
sampl
incub
higher
humid
condit
gener
stabl
addit
enhanc
stabil
regardless
level
humid
data
support
conclus
nt
particl
effici
stabil
infecti
viru
elev
dri
humid
condit
extend
amount
time
better
illustr
applic
clinic
sampl
infect
mice
via
intranas
infect
measur
viral
load
mous
blood
day
postinfect
dpi
follow
suppli
demonstr
preserv
capabl
nt
particl
ex
vivo
sinc
mous
blood
sampl
day
show
highest
viral
rna
concentr
among
test
time
point
figur
use
blood
harvest
mice
dpi
ad
compar
capsid
protein
stabil
without
nt
particl
indic
amount
time
experi
perform
whole
blood
absenc
nt
particl
veev
capsid
undetect
time
point
figur
incub
mous
blood
enabl
capsid
detect
time
point
highlight
potenti
use
nt
particl
clinic
sampl
nt
particl
made
hydrogel
matrix
custom
variou
affin
bait
acryl
acid
cibacron
blue
dye
reactiv
red
dye
polymer
bind
rang
biomolecul
previou
studi
found
nt
particl
contain
reactiv
red
affin
bait
allow
nt
particl
captur
wide
rang
rna
virus
use
newli
develop
magnet
nt
particl
could
simplifi
workflow
allow
isol
nt
particl
instead
long
centrifug
step
process
allow
virion
present
clinic
sampl
bound
nt
particl
easili
quickli
separ
bodi
fluid
use
either
manual
autom
method
howev
one
obstacl
pathogen
identif
whole
blood
natur
abund
host
protein
red
blood
cell
prevent
direct
identif
pathogen
blood
often
requir
addit
prepar
step
anoth
inconveni
relat
work
whole
blood
bodi
fluid
sampl
necess
keep
low
temperatur
transport
obstacl
make
blood
difficult
matrix
sampl
prepar
diagnost
analysi
howev
despit
exist
abovement
obstacl
observ
effici
separ
veev
viral
particl
blood
nt
particl
variou
temperatur
humid
condit
moreov
nt
particl
effici
preserv
infecti
veev
condit
otherwis
undetect
much
nt
particl
work
shown
signific
benefit
preserv
enhanc
detect
veev
virion
confirm
stabil
viral
capsid
protein
viral
rna
well
infecti
virion
limit
use
nt
particl
environment
condit
harsh
nt
particl
capabl
partial
allevi
neg
effect
despit
trend
show
preserv
via
nt
particl
viral
titer
later
time
point
exhibit
statist
differ
suggest
preserv
nt
particl
may
suffici
prevent
ultim
decay
virion
extrem
environment
condit
anoth
limit
use
nt
particl
difficulti
separ
virion
nt
particl
previous
shown
strong
bind
rvfv
virion
nt
particl
work
rvfv
abl
elut
total
virion
bound
nt
purpos
use
sodium
chlorid
highest
concentr
induc
viru
degrad
even
concentr
enough
complet
elut
virion
nt
although
strong
lysi
buffer
trizol
reagent
ripa
buffer
util
precipit
rna
extract
viral
protein
diagnosi
purpos
found
method
elut
virion
retain
viral
infect
shown
electron
micrograph
figur
nt
particl
potenti
bound
dozen
virion
indic
effici
captur
abil
nt
particl
howev
principl
plaqu
assay
dilut
viral
sampl
singl
virion
form
plaqu
call
plaqueform
unit
visual
countabl
investig
overwhelm
captur
affin
nt
particl
virion
obstacl
accuraci
plaqu
assay
method
might
lead
underestim
initi
viral
titer
figur
therefor
better
way
elut
virion
need
develop
enabl
accur
viral
titer
determin
one
possibl
futur
test
competit
elut
veev
via
addit
increas
concentr
reactiv
red
affin
bait
despit
limit
discuss
data
indic
nt
particl
use
innov
research
nt
particl
custom
variou
affin
bait
bind
differ
microorgan
biomolecul
addit
virus
nt
particl
shown
capabl
bind
outer
surfac
protein
borrelia
bacteria
caus
lyme
diseas
increas
specif
diagnosi
earli
stage
lyme
diseas
also
biomark
clinic
fluid
sampl
secret
extracellular
organel
like
exosom
captur
sensit
detect
enhanc
via
nt
particl
abil
nt
particl
preserv
veev
compon
includ
capsid
protein
genom
rna
complex
matrix
whole
blood
highlight
import
studi
capabl
nt
particl
overal
magnet
nt
particl
present
studi
demonstr
effici
bind
affin
captur
one
biolog
warfar
agent
veev
allow
laboratori
technician
detect
particular
pathogen
clinic
sampl
patient
soldier
front
line
moreov
high
effici
preserv
live
pathogen
protein
nucleic
acid
make
nt
particl
attract
candid
use
stabil
agent
new
blood
collect
medic
devic
current
undergo
develop
test
henc
util
nt
particl
altern
method
enhanc
surveil
system
monitor
prevent
outbreak
studi
provid
mechanist
insight
broad
use
nt
particl
dataset
gener
studi
includ
articlesupplementari
materi
anim
studi
review
approv
georg
mason
univers
institut
anim
care
use
committe
ap
bl
employ
compani
cere
nanosci
inc
kkh
member
scientif
advisori
board
cere
nanosci
inc
bl
sharehold
cere
nanosci
inc
nanoparticl
use
studi
research
grade
provid
cere
nanosci
inc
commerci
avail
product
author
declar
tasso
inc
role
design
studi
collect
analysi
interpret
data
write
manuscript
remain
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
